(RejuvenAir) Evaluating the effectiveness of a new treatment device for moderate to severe chronic obstructive pulmonary disease with chronic bronchitis

The PI of this project was:

This project was funded by: CSA Medical, Inc.

The term of this project was: February 2020 to October 2023

The number of subjects scanned during this project was: 11